Wells Fargo & Company Lowers Clorox (NYSE:CLX) Price Target to $95.00

Clorox (NYSE:CLX) had its price target reduced by research analysts at Wells Fargo & Company from $100.00 to $95.00 in a research report issued on Monday,MarketScreener reports. Wells Fargo & Company‘s price objective would indicate a potential upside of 2.74% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the stock. BNP Paribas Exane cut their target price on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research report on Tuesday, May 12th. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Royal Bank Of Canada cut their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Finally, Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Performance

CLX opened at $92.47 on Monday. The stock has a market cap of $11.18 billion, a P/E ratio of 15.05, a P/E/G ratio of 0.47 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock’s 50 day simple moving average is $101.99 and its 200 day simple moving average is $106.90. Clorox has a 1-year low of $84.70 and a 1-year high of $136.69.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s revenue was up .1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts anticipate that Clorox will post 5.63 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

A number of hedge funds have recently made changes to their positions in CLX. Center for Financial Planning Inc. acquired a new position in shares of Clorox during the third quarter worth about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox during the 3rd quarter worth approximately $25,000. Root Financial Partners LLC acquired a new position in Clorox during the 3rd quarter worth approximately $29,000. Darwin Wealth Management LLC purchased a new position in Clorox in the 2nd quarter worth approximately $29,000. Finally, Caitlin John LLC grew its position in Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.